What is Innovex International Inc's earnings per share (EPS)?

Innovex International Inc (INVX) reported diluted earnings per share of $1.20 for fiscal year 2025. This represents a -56.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Innovex International Inc Financials

INVX

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Innovex International Inc (INVX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 76/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Innovex International Inc has an operating margin of 13.6%, meaning the company retains $14 of operating profit per $100 of revenue. This results in a moderate score of 52/100, indicating healthy but not exceptional operating efficiency. This is up from 7.4% the prior year.

Growth

100

Innovex International Inc's revenue surged 48.0% year-over-year to $978.3M, reflecting rapid business expansion. This strong growth earns a score of 100/100.

Leverage

100

Innovex International Inc carries a low D/E ratio of 0.02, meaning only $0.02 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

With a current ratio of 4.91, Innovex International Inc holds $4.91 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 98/100.

Returns

Innovex International Inc generates a 7.9% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 29/100. This is down from 14.6% the prior year.

Altman Z-Score Safe

6.76

Innovex International Inc scores 6.76, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($1.7B) relative to total liabilities ($210.6M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Strong

7/9

Innovex International Inc passes 7 of 9 financial strength tests. 3 of 4 profitability signals pass, all 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

2.29x

For every $1 of reported earnings, Innovex International Inc generates $2.29 in operating cash flow ($190.9M OCF vs $83.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

51.4x

Innovex International Inc earns $51.4 in operating income for every $1 of interest expense ($132.6M vs $2.6M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$978.3M

YoY+48.0%

5Y CAGR+21.8%

10Y CAGR+1.5%

Innovex International Inc generated $978.3M in revenue in fiscal year 2025. This represents an increase of 48.0% from the prior year.

EBITDA

$193.4M

YoY+140.9%

10Y CAGR-3.6%

Innovex International Inc's EBITDA was $193.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 140.9% from the prior year.

Net Income

$83.3M

YoY-40.6%

10Y CAGR-8.0%

Innovex International Inc reported $83.3M in net income in fiscal year 2025. This represents a decrease of 40.6% from the prior year.

EPS (Diluted)

$1.20

YoY-56.7%

10Y CAGR-13.3%

Innovex International Inc earned $1.20 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 56.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$203.4M

YoY+177.6%

5Y CAGR-10.1%

10Y CAGR-6.1%

Innovex International Inc held $203.4M in cash against $18.9M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

69M

YoY-0.1%

5Y CAGR+14.3%

10Y CAGR+6.2%

Innovex International Inc had 69M shares outstanding in fiscal year 2025. This represents a decrease of 0.1% from the prior year.

Margins & Returns

Gross Margin

31.0%

YoY-4.2pp

5Y CAGR+4.9pp

10Y CAGR-14.6pp

Innovex International Inc's gross margin was 31.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 4.2 percentage points from the prior year.

Operating Margin

13.6%

YoY+6.1pp

5Y CAGR+31.0pp

10Y CAGR-15.9pp

Innovex International Inc's operating margin was 13.6% in fiscal year 2025, reflecting core business profitability. This is up 6.1 percentage points from the prior year.

Net Margin

8.5%

YoY-12.7pp

5Y CAGR+16.9pp

10Y CAGR-14.2pp

Innovex International Inc's net profit margin was 8.5% in fiscal year 2025, showing the share of revenue converted to profit. This is down 12.7 percentage points from the prior year.

Return on Equity

7.9%

YoY-6.8pp

5Y CAGR+10.8pp

10Y CAGR-6.6pp

Innovex International Inc's ROE was 7.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 6.8 percentage points from the prior year.

Capital Allocation

R&D Spending

$6.7M

YoY+81.1%

Innovex International Inc invested $6.7M in research and development in fiscal year 2025. This represents an increase of 81.1% from the prior year.

Share Buybacks

$9.3M

5Y CAGR-18.0%

10Y CAGR-18.9%

Innovex International Inc spent $9.3M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

N/A

INVX Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$978.3M+48.0%	$660.8M+18.9%	$555.5M+53.5%	$361.9M+12.2%	$322.4M-11.7%	$365.0M
Cost of Revenue	$675.0M+57.6%	$428.2M+18.9%	$360.1M+16.5%	$309.1M-0.1%	$309.3M+14.7%	$269.7M
Gross Profit	$303.3M+30.4%	$232.6M+19.0%	$195.4M+269.8%	$52.9M+300.9%	$13.2M-86.2%	$95.3M
R&D Expenses	$6.7M+81.1%	$3.7M+23.3%	$3.0M+20.0%	$2.5M	N/A	N/A
SG&A Expenses	$128.8M+10.9%	$116.2M+59.6%	$72.8M+23.0%	$59.2M-48.5%	$115.0M+21.0%	$95.1M
Operating Income	$132.6M+170.2%	$49.1M-49.6%	$97.3M+28.3%	$75.8M+160.5%	-$125.3M-97.2%	-$63.6M
Interest Expense	$2.6M+6.3%	$2.4M-55.9%	$5.5M+36.5%	$4.0M+412.6%	$787K+26.7%	$621K
Income Tax	$45.2M+1718.7%	$2.5M-87.8%	$20.4M+111.8%	$9.7M+227.6%	$2.9M+109.4%	-$31.3M
Net Income	$83.3M-40.6%	$140.3M+89.8%	$73.9M+16.8%	$63.3M+149.2%	-$128.5M-317.6%	-$30.8M
EPS (Diluted)	$1.20-56.7%	$2.77+21.0%	$2.29+13.9%	$2.01+155.4%	$-3.63-317.2%	$-0.87

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$273.6M+14.0%	$240.0M+7.0%	$224.2M-6.7%	$240.4M-13.6%	$278.3M+83.3%	$151.8M+26.2%	$120.3M+9.1%	$110.3M
Cost of Revenue	$194.5M+18.5%	$164.1M+7.6%	$152.5M-7.0%	$163.9M-1.1%	$165.8M+67.3%	$99.1M+17.6%	$84.3M+6.8%	$78.9M
Gross Profit	$79.1M+4.2%	$75.9M+5.9%	$71.7M-6.3%	$76.5M-32.0%	$112.5M+113.6%	$52.7M+46.2%	$36.0M+14.8%	$31.4M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$32.0M-9.9%	$35.6M+23.4%	$28.8M-10.9%	$32.3M-15.5%	$38.3M+0.8%	$38.0M+104.4%	$18.6M-12.9%	$21.3M
Operating Income	$25.8M-58.6%	$62.3M+174.4%	$22.7M+3.9%	$21.9M-18.8%	$26.9M+303.6%	-$13.2M-201.1%	$13.1M-41.4%	$22.3M
Interest Expense	$654K-3.4%	$677K+22.9%	$551K-21.3%	$700K+86.7%	$375K-48.6%	$729K+20.1%	$607K-15.6%	$719K
Income Tax	$13.0M-30.6%	$18.7M+171.9%	$6.9M+4.3%	$6.6M+251.0%	-$4.4M-69.1%	-$2.6M-159.8%	$4.3M-15.6%	$5.1M
Net Income	$14.0M-64.4%	$39.2M+155.6%	$15.3M+4.0%	$14.8M-53.6%	$31.8M-61.5%	$82.6M+766.2%	$9.5M-41.9%	$16.4M
EPS (Diluted)	N/A	$0.57+159.1%	$0.22+4.8%	$0.21	N/A	$1.99+563.3%	$0.30-41.2%	$0.51

INVX Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$1.3B+5.9%	$1.2B+151.9%	$475.3M-51.0%	$970.0M-4.0%	$1.0B-12.3%	$1.2B
Current Assets	$728.0M+13.5%	$641.4M+122.5%	$288.3M-61.6%	$750.0M+0.7%	$745.1M-13.7%	$863.2M
Cash & Equivalents	$203.4M+177.6%	$73.3M-60.9%	$187.3M-27.8%	$259.4M-27.0%	$355.5M+2.7%	$346.0M
Inventory	$248.4M-8.4%	$271.2M+92.1%	$141.2M-3.3%	$146.0M+0.2%	$145.7M-31.4%	$212.5M
Accounts Receivable	$237.8M-0.7%	$239.5M+102.4%	$118.4M+30.3%	$90.9M-9.6%	$100.5M-13.5%	$116.2M
Goodwill	$99.7M+65.7%	$60.2M+151.4%	$23.9M0.0%	$23.9M	N/A	N/A
Total Liabilities	$210.6M-12.0%	$239.3M+63.5%	$146.4M-79.6%	$718.7M-13.3%	$829.4M+656.4%	$109.6M
Current Liabilities	$148.2M-8.9%	$162.7M+106.9%	$78.6M-10.2%	$87.6M-6.5%	$93.7M+9.5%	$85.5M
Long-Term Debt	$18.9M-25.6%	$25.4M-37.3%	$40.6M	N/A	N/A	N/A
Total Equity	$1.1B+10.4%	$958.2M+191.3%	$328.9M+30.9%	$251.3M+39.2%	$180.6M-82.7%	$1.0B
Retained Earnings	$285.3M+35.0%	$211.3M+44.8%	$145.9M-84.6%	$950.2M-2.4%	$973.1M-13.5%	$1.1B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$1.3B+1.1%	$1.3B+2.2%	$1.2B+2.6%	$1.2B-0.1%	$1.2B+5.7%	$1.1B+12.4%	$1.0B-1.3%	$1.0B
Current Assets	$728.0M+2.5%	$710.4M+6.0%	$670.1M+5.9%	$632.6M-1.4%	$641.4M-5.3%	$677.3M-4.3%	$707.5M-1.1%	$715.1M
Cash & Equivalents	$203.4M+24.5%	$163.4M+137.5%	$68.8M+1.0%	$68.1M-7.0%	$73.3M-26.6%	$99.9M-46.2%	$185.6M-6.3%	$198.2M
Inventory	$248.4M-9.7%	$275.2M-1.2%	$278.5M+3.4%	$269.3M-0.7%	$271.2M-8.9%	$297.5M+45.3%	$204.7M-2.1%	$209.2M
Accounts Receivable	$237.8M+7.9%	$220.4M-0.3%	$221.0M-6.4%	$236.0M-1.5%	$239.5M+6.4%	$225.1M+46.0%	$154.2M+12.4%	$137.1M
Goodwill	$99.7M+4.5%	$95.4M+1.3%	$94.1M+24.6%	$75.6M+25.6%	$60.2M+151.4%	$23.9M+48.4%	$16.1M-1.0%	$16.3M
Total Liabilities	$210.6M-2.0%	$215.0M-7.2%	$231.5M+6.4%	$217.6M-9.1%	$239.3M+4.8%	$228.4M-65.2%	$655.7M-3.1%	$676.7M
Current Liabilities	$148.2M-0.4%	$148.7M+2.0%	$145.7M-0.1%	$145.8M-10.4%	$162.7M-6.9%	$174.8M+38.3%	$126.4M-5.3%	$133.6M
Long-Term Debt	$18.9M-5.8%	$20.1M-42.2%	$34.8M+76.7%	$19.7M-22.6%	$25.4M+105.9%	$12.4M	N/A	N/A
Total Equity	$1.1B+1.8%	$1.0B+4.4%	$995.6M+1.8%	$978.4M+2.1%	$958.2M+5.9%	$904.4M+156.6%	$352.5M+2.4%	$344.3M
Retained Earnings	$285.3M+5.1%	$271.3M+16.9%	$232.1M+3.0%	$225.4M+6.7%	$211.3M+17.7%	$179.5M-80.7%	$929.0M-0.2%	$930.8M

INVX Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$190.9M+104.3%	$93.4M+23.2%	$75.9M+1405.5%	-$5.8M-115.1%	$38.4M+282.2%	-$21.1M
Capital Expenditures	N/A	N/A	$32.6M+72.9%	$18.9M+88.8%	$10.0M-16.4%	$11.9M
Free Cash Flow	N/A	N/A	$43.2M+275.2%	-$24.7M-186.8%	$28.4M+186.1%	-$33.0M
Investing Cash Flow	-$18.7M-123.9%	$78.4M+341.9%	-$32.4M+13.6%	-$37.5M-1070.0%	-$3.2M+43.0%	-$5.6M
Financing Cash Flow	-$44.9M+56.4%	-$103.1M-131.3%	-$44.6M-205.4%	$42.3M+274.0%	-$24.3M+3.5%	-$25.2M
Dividends Paid	$0-100.0%	$75.0M	$0	$0	N/A	N/A
Share Buybacks	$9.3M	$0	$0-100.0%	$20.8M-14.0%	$24.2M-3.2%	$25.0M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$52.2M+8.0%	$48.4M-18.3%	$59.2M+90.4%	$31.1M-14.5%	$36.3M+67.3%	$21.7M-4.6%	$22.8M+80.6%	$12.6M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	$6.2M+29.4%	$4.8M
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	$16.6M+111.7%	$7.8M
Investing Cash Flow	-$10.0M-112.8%	$77.6M+223.4%	-$62.9M-167.9%	-$23.5M+67.4%	-$72.0M-146.8%	$153.7M+14215.2%	-$1.1M+51.1%	-$2.2M
Financing Cash Flow	-$2.8M+91.1%	-$31.2M-1376.7%	$2.4M+118.2%	-$13.4M-220.3%	$11.1M+113.1%	-$85.3M-357.0%	-$18.7M-82.0%	-$10.3M
Dividends Paid	$0	N/A	N/A	N/A	$0	N/A	N/A	N/A
Share Buybacks	$0	$0-100.0%	$8.7M+1282.4%	$626K	$0	$0	$0	$0

INVX Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	31.0%-4.2pp	35.2%+0.0pp	35.2%+20.6pp	14.6%+10.5pp	4.1%-22.0pp	26.1%
Operating Margin	13.6%+6.1pp	7.4%-10.1pp	17.5%-3.5pp	21.0%+59.8pp	-38.9%-21.5pp	-17.4%
Net Margin	8.5%-12.7pp	21.2%+7.9pp	13.3%-4.2pp	17.5%+57.3pp	-39.9%-31.4pp	-8.4%
Return on Equity	7.9%-6.8pp	14.6%-7.8pp	22.5%-2.7pp	25.2%+96.4pp	-71.2%-68.2pp	-2.9%
Return on Assets	6.6%-5.2pp	11.7%-3.8pp	15.6%+9.0pp	6.5%+19.2pp	-12.7%-10.1pp	-2.7%
Current Ratio	4.91+1.0	3.94+0.3	3.67-4.9	8.57+0.6	7.95-2.1	10.09
Debt-to-Equity	0.020.0	0.03-0.1	0.12-2.7	2.86-1.7	4.59+4.5	0.11
FCF Margin	N/A	N/A	7.8%+14.6pp	-6.8%-15.6pp	8.8%+17.9pp	-9.0%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	28.9%-2.7pp	31.6%-0.3pp	32.0%+0.2pp	31.8%-8.6pp	40.4%+5.7pp	34.7%+4.8pp	29.9%+1.5pp	28.5%
Operating Margin	9.4%-16.5pp	25.9%+15.8pp	10.1%+1.0pp	9.1%-0.6pp	9.7%+18.4pp	-8.7%-19.6pp	10.9%-9.4pp	20.2%
Net Margin	5.1%-11.2pp	16.4%+9.5pp	6.8%+0.7pp	6.1%-5.3pp	11.4%-43.0pp	54.4%+46.5pp	7.9%-7.0pp	14.9%
Return on Equity	1.3%-2.5pp	3.8%+2.2pp	1.5%+0.0pp	1.5%-1.8pp	3.3%-5.8pp	9.1%+6.4pp	2.7%-2.1pp	4.8%
Return on Assets	1.1%-2.0pp	3.1%+1.9pp	1.3%+0.0pp	1.2%-1.4pp	2.6%-4.6pp	7.3%+6.3pp	0.9%-0.7pp	1.6%
Current Ratio	4.91+0.1	4.78+0.2	4.60+0.3	4.34+0.4	3.94+0.1	3.87-1.7	5.60+0.2	5.35
Debt-to-Equity	0.020.0	0.02-0.0	0.03+0.0	0.020.0	0.03+0.0	0.01-1.8	1.86-0.1	1.97
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	13.8%+6.7pp	7.1%

Similar Companies

Enerflex EFXT

$2.5B

Bristow Group Inc VTOL

$1.4B

Select Water Solutions WTTR

$1.8B

National Energy Services Reuni NESR

$2.3B

Mrc Global Inc MRC

$1.2B

Frequently Asked Questions

What is Innovex International Inc's annual revenue?

Innovex International Inc (INVX) reported $978.3M in total revenue for fiscal year 2025. This represents a 48.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Innovex International Inc's revenue growing?

Innovex International Inc (INVX) revenue grew by 48% year-over-year, from $660.8M to $978.3M in fiscal year 2025.

Is Innovex International Inc profitable?

Yes, Innovex International Inc (INVX) reported a net income of $83.3M in fiscal year 2025, with a net profit margin of 8.5%.

What is Innovex International Inc's EBITDA?

Innovex International Inc (INVX) had EBITDA of $193.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Innovex International Inc have?

As of fiscal year 2025, Innovex International Inc (INVX) had $203.4M in cash and equivalents against $18.9M in long-term debt.

What is Innovex International Inc's gross margin?

Innovex International Inc (INVX) had a gross margin of 31.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Innovex International Inc's operating margin?

Innovex International Inc (INVX) had an operating margin of 13.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Innovex International Inc's net profit margin?

Innovex International Inc (INVX) had a net profit margin of 8.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Innovex International Inc's return on equity (ROE)?

Innovex International Inc (INVX) has a return on equity of 7.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Innovex International Inc's operating cash flow?

Innovex International Inc (INVX) generated $190.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Innovex International Inc's total assets?

Innovex International Inc (INVX) had $1.3B in total assets as of fiscal year 2025, including both current and long-term assets.

How much does Innovex International Inc spend on research and development?

Innovex International Inc (INVX) invested $6.7M in research and development during fiscal year 2025.

Does Innovex International Inc buy back shares?

Yes, Innovex International Inc (INVX) spent $9.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Innovex International Inc have outstanding?

Innovex International Inc (INVX) had 69M shares outstanding as of fiscal year 2025.

What is Innovex International Inc's current ratio?

Innovex International Inc (INVX) had a current ratio of 4.91 as of fiscal year 2025, which is generally considered healthy.

What is Innovex International Inc's debt-to-equity ratio?

Innovex International Inc (INVX) had a debt-to-equity ratio of 0.02 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Innovex International Inc's return on assets (ROA)?

Innovex International Inc (INVX) had a return on assets of 6.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Innovex International Inc's Altman Z-Score?

Innovex International Inc (INVX) has an Altman Z-Score of 6.76, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Innovex International Inc's Piotroski F-Score?

Innovex International Inc (INVX) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Innovex International Inc's earnings high quality?

Innovex International Inc (INVX) has an earnings quality ratio of 2.29x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Innovex International Inc cover its interest payments?

Innovex International Inc (INVX) has an interest coverage ratio of 51.4x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Innovex International Inc?

Innovex International Inc (INVX) scores 76 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.